The EGFR-mutated subtype displayed higher mutation rates of SFG than the EGFR-wildtype subtype in pan-cancer and in six individual cancer types (ACC, COAD, LUSC, SKCM, STAD, and UCEC). Here, EGFR is linked to cancer.